Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus

Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes

NCT01129258 ·Status: COMPLETED ·Phase: PHASE1

Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes

NCT02220907 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes Mellitus

NCT04889157 ·Status: COMPLETED ·Phase: PHASE1

A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus

NCT01792635 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 Diabetes

NCT02081599 ·Status: COMPLETED ·Phase: PHASE4

A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

NCT02628392 ·Status: COMPLETED ·Phase: NA

A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus

NCT02211261 ·Status: COMPLETED ·Phase: PHASE1

MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study in Patients With Type 2 Diabetes

NCT01517321 ·Status: COMPLETED ·Phase: PHASE3

MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).

NCT00754130 ·Status: COMPLETED ·Phase: PHASE1

Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes

NCT01272804 ·Status: COMPLETED ·Phase: PHASE1

Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients

NCT02314637 ·Status: COMPLETED ·Phase: PHASE3

Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus

NCT00057317 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06882961 in Japanese Adults With Type 2 Diabetes Mellitus

NCT04552470 ·Status: COMPLETED ·Phase: PHASE1

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin

NCT02053103 ·Status: TERMINATED ·Phase: PHASE2

MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes Mellitus

NCT00854035 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus

NCT02175121 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 Diabetes

NCT01026194 ·Status: COMPLETED ·Phase: PHASE3

Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus

NCT00530309 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes

NCT00974090 ·Status: COMPLETED ·Phase: PHASE3

Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus

NCT00513214 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.

NCT05363774 ·Status: COMPLETED ·Phase: PHASE1

PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus Patients

NCT01856595 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes

NCT00628212 ·Status: COMPLETED ·Phase: PHASE2

A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes

NCT01469065 ·Status: COMPLETED ·Phase: PHASE1

A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.

NCT00517465 ·Status: COMPLETED ·Phase: PHASE1